ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Immunovia Ab (publ)

Immunovia Ab (publ) (0G8X)

191,40
0,00
(0,00%)
Fermé 14 Janvier 5:30PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
191,40
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
191,40 Plage de 52 semaines 191,40
Cap du marché
Clôture Veille
191,40
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
6 831
Actions en circulation
45 287 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,01
Bénéfice par action (BPA)
-6,83
Chiffre d'affairess
1,65M
Bénéfice net
-309,44M

À propos de Immunovia Ab (publ)

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Siège social
Lund, Swe
Fondé
-
Immunovia Ab (publ) est coté dans le secteur Surgical,med Instr,apparatus de la London Stock Exchange avec le ticker 0G8X. Le dernier cours de clôture d'Immunovia Ab (publ) était de SEK191,40. Au cours de la dernière année, les actions de Immunovia Ab (publ) ont été négociées dans une fourchette de prix de SEK 191,40 à SEK 191,40.

Immunovia Ab (publ) compte actuellement 45 287 000 actions en circulation. La capitalisation boursière d'Immunovia Ab (publ) est de SEK8,67 milliard. Immunovia Ab (publ) a un ratio cours/bénéfice (ratio PE) de -0.01.

0G8X Dernières nouvelles

Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme

Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme PR Newswire LUND, Sweden, Dec. 28, 2024 LUND, Sweden, Dec. 28, 2024...

Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme

Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme PR Newswire LUND, Sweden, Dec. 28, 2024 LUND, Sweden, Dec. 28, 2024...

End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding

End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding PR Newswire LUND, Sweden, Dec. 19, 2024 LUND, Sweden, Dec. 19, 2024 /PRNewswire/ -- As we near the holidays and year end, I am...

Immunovia announces financial calendar for financial year 2024

Immunovia announces financial calendar for financial year 2024 PR Newswire LUND, Sweden, Jan. 4, 2024 LUND, Sweden, Jan. 4, 2024 /PRNewswire/ -- Immunovia, a diagnostic company with the vision to...

Immunovia announces financial calendar for financial year 2024

Immunovia announces financial calendar for financial year 2024 PR Newswire LUND, Sweden, Jan. 4, 2024 LUND, Sweden, Jan. 4, 2024 /PRNewswire/ -- Immunovia, a diagnostic company with the vision to...

Bulletin from the extraordinary general meeting in Immunovia AB

Bulletin from the extraordinary general meeting in Immunovia AB PR Newswire LUND, Sweden, Nov. 21, 2023 LUND, Sweden, Nov. 21, 2023 /PRNewswire/ -- On 21st November 2023, an extraordinary general...

Bulletin from the extraordinary general meeting in Immunovia AB

Bulletin from the extraordinary general meeting in Immunovia AB PR Newswire LUND, Sweden, Nov. 21, 2023 LUND, Sweden, Nov. 21, 2023 /PRNewswire/ -- On 21st November 2023, an extraordinary general...

Immunovia Publishes Interim Report for January-September 2023

Immunovia Publishes Interim Report for January-September 2023 PR Newswire LUND, Sweden, Nov. 9, 2023 LUND, Sweden, Nov. 9, 2023 /PRNewswire/ -- July-September 2023 Net sales amounted to KSEK 488...

Immunovia Publishes Interim Report for January-September 2023

Immunovia Publishes Interim Report for January-September 2023 PR Newswire LUND, Sweden, Nov. 9, 2023 LUND, Sweden, Nov. 9, 2023 /PRNewswire/ -- July-September 2023 Net sales amounted to KSEK 488...

Immunovia successfully completes discovery phase of next-generation test development

Immunovia successfully completes discovery phase of next-generation test development PR Newswire LUND, Sweden, Nov. 7, 2023 LUND, Sweden, Nov. 7, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm:...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
100191.4191.4191.400DE
400191.4191.4191.411546191.4DE
1200191.4191.4191.46831191.4DE
2600191.4191.4191.44210191.4DE
5200191.4191.4191.42599191.4DE
15600191.4191.4191.42426191.4DE
26000191.4191.4191.41577191.4DE

0G8X - Frequently Asked Questions (FAQ)

What is the current Immunovia Ab (publ) share price?
The current share price of Immunovia Ab (publ) is SEK 191,40
How many Immunovia Ab (publ) shares are in issue?
Immunovia Ab (publ) has 45 287 000 shares in issue
What is the market cap of Immunovia Ab (publ)?
The market capitalisation of Immunovia Ab (publ) is SEK 8,67B
What is the 1 year trading range for Immunovia Ab (publ) share price?
Immunovia Ab (publ) has traded in the range of SEK 191,40 to SEK 191,40 during the past year
What is the PE ratio of Immunovia Ab (publ)?
The price to earnings ratio of Immunovia Ab (publ) is -0,01
What is the cash to sales ratio of Immunovia Ab (publ)?
The cash to sales ratio of Immunovia Ab (publ) is 1,37
What is the reporting currency for Immunovia Ab (publ)?
Immunovia Ab (publ) reports financial results in SEK
What is the latest annual turnover for Immunovia Ab (publ)?
The latest annual turnover of Immunovia Ab (publ) is SEK 1,65M
What is the latest annual profit for Immunovia Ab (publ)?
The latest annual profit of Immunovia Ab (publ) is SEK -309,44M
What is the registered address of Immunovia Ab (publ)?
The registered address for Immunovia Ab (publ) is MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 63
What is the Immunovia Ab (publ) website address?
The website address for Immunovia Ab (publ) is www.immunovia.com
Which industry sector does Immunovia Ab (publ) operate in?
Immunovia Ab (publ) operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TRLSTrellus Health Plc
4,95p
(725,00%)
200,39M
ALKAlkemy Capital Investments Plc
172,50p
(32,69%)
271,97k
PYCPhysiomics Plc
1,00p
(29,03%)
35,26M
NFXNuformix Plc
0,06p
(26,32%)
222,56M
FOGFalcon Oil & Gas Ltd.
7,25p
(23,93%)
765,79k
THRUThruvision Group Plc
3,00p
(-53,85%)
284,85k
MRITMerit Group Plc
17,50p
(-42,62%)
106,32k
RCGHRc365 Holding Plc
2,25p
(-35,16%)
29,28M
BLUBlue Star Capital Plc
5,75p
(-30,30%)
1,17M
MOSMobile Streams Plc
0,34p
(-27,66%)
84,28M
TRPTower Resources Plc
0,034p
(-4,23%)
1,36B
MSMNMosman Oil And Gas Limited
0,0325p
(6,56%)
570,69M
SYMESupply@me Capital Plc
0,0032p
(-13,51%)
339,48M
ENETEthernity Networks Ltd
0,12p
(6,67%)
314,93M
NTVONativo Resources Plc
0,0019p
(-5,00%)
304,91M
Aucune Discussion Trouvée
Ajouter une Discussion